Clinical Trials
2 trialsNCT02411656 2026-01-23
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03344796 2023-07-27
UV Exposure Assessed With Wearable Sensor and Sun Protection
Northwestern University
Phase NA Completed